Treating Alzheimer’s early can reduce disease progression – 07/18/2023 – Equilibrium
Treating Alzheimer's patients as early as possible, when symptoms and brain pathology are milder, offers a better chance of slowing...
Treating Alzheimer's patients as early as possible, when symptoms and brain pathology are milder, offers a better chance of slowing...
Almost no Brazilian who suffered a heart attack or stroke (CVA) and is monitored by the Family Health Strategy (ESF)...
An experimental drug for Alzheimer's disease has passed an initial safety assessment and will move on to a larger trial,...
This is the edition of the newsletter Cuide-se this Monday (10). Do you want to receive it in your email?...
A good part of the decisions will still be taken in a supplementary law, which will specify items left open...
With the approval of the Alzheimer's drug Leqembi, from pharmaceuticals Elisai and Biogen, in the United States, Wall Street analysts...
The Government of Amapá invested more than BRL 32 million in strengthening pharmaceutical assistance, in the first 180 days of...
The United States Food and Drug Administration (FDA) approved this Thursday (6) the drug lecanemab, to be marketed as Leqembi,...
A study conducted at USP reveals that brilacidin, a new drug tested for illnesses ranging from bacterial skin infections to...
Two studies presented at the end of June at the meeting of the American Association for Diabetes (ADA) observed a...
Anvisa (National Health Surveillance Agency) granted registration to Sybrava, a new injectable medicine manufactured by Novartis and used to control...
The same medicine can cost up to R$ 27.61 more in pharmacies in the city of São Paulo, according to...